235 related articles for article (PubMed ID: 32077332)
21. Intestinal Efflux Transporters P-gp and BCRP Are Not Clinically Relevant in Apixaban Disposition.
Sodhi JK; Liu S; Benet LZ
Pharm Res; 2020 Sep; 37(10):208. PubMed ID: 32996065
[TBL] [Abstract][Full Text] [Related]
22. Genomic resources for dissecting the role of non-protein coding variation in gene-environment interactions.
Levings D; Shaw KE; Lacher SE
Toxicology; 2020 Aug; 441():152505. PubMed ID: 32450112
[TBL] [Abstract][Full Text] [Related]
23. Transcription factor-mediated regulation of the BCRP/
Gorczyca L; Aleksunes LM
Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):239-253. PubMed ID: 32077332
[No Abstract] [Full Text] [Related]
24. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
Han LW; Gao C; Mao Q
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
[TBL] [Abstract][Full Text] [Related]
25. [Transcriptional regulation of breast cancer resistance protein].
Wu XG; Peng SB; Huang Q
Yi Chuan; 2012 Dec; 34(12):1529-36. PubMed ID: 23262099
[TBL] [Abstract][Full Text] [Related]
26. Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPAR
Kukal S; Bora S; Kanojia N; Singh P; Paul PR; Rawat C; Sagar S; Bhatraju NK; Grewal GK; Singh A; Kukreti S; Satyamoorthy K; Kukreti R
Mol Pharmacol; 2023 Mar; 103(3):145-157. PubMed ID: 36414374
[TBL] [Abstract][Full Text] [Related]
27. Interaction of WBP2 with ERĪ± increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription.
Chen S; Wang H; Li Z; You J; Wu QW; Zhao C; Tzeng CM; Zhang ZM
Br J Cancer; 2018 May; 119(2):182-192. PubMed ID: 29937544
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
[TBL] [Abstract][Full Text] [Related]
29. Leflunomide Increases Hepatic Exposure to Methotrexate and Its Metabolite by Differentially Regulating Multidrug Resistance-Associated Protein Mrp2/3/4 Transporters via Peroxisome Proliferator-Activated Receptor
Wang L; Ma L; Lin Y; Liu X; Xiao L; Zhang Y; Xu Y; Zhou H; Pan G
Mol Pharmacol; 2018 Jun; 93(6):563-574. PubMed ID: 29618584
[TBL] [Abstract][Full Text] [Related]
30. Interindividual Regulation of the Breast Cancer Resistance Protein/
Bircsak KM; Moscovitz JE; Wen X; Archer F; Yuen PYS; Mohammed M; Memon N; Weinberger BI; Saba LM; Vetrano AM; Aleksunes LM
Drug Metab Dispos; 2018 May; 46(5):619-627. PubMed ID: 29386232
[TBL] [Abstract][Full Text] [Related]
31. NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells.
Choi BH; Ryu DY; Ryoo IG; Kwak MK
Oncotarget; 2017 Dec; 8(63):107188-107205. PubMed ID: 29291022
[TBL] [Abstract][Full Text] [Related]
32. Impact of Breast Cancer Resistance Protein Expression on the In Vitro Efficacy of Anticancer Drugs in Pancreatic Cancer Cell Lines.
Washio I; Nakanishi T; Ishiguro N; Yamamura N; Tamai I
Drug Metab Dispos; 2018 Mar; 46(3):214-222. PubMed ID: 29246888
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
